Hemostasis Ninja Nerd Notes

Factors Maintaining Natural Blood Thinness

  • Before delving into hemostasis, it's essential to understand what prevents blood from coagulating unnaturally.

  • Endothelial Cells:
      - These cells line the interior surface of blood vessels and play a critical role in hemostasis.
      - Underneath endothelial cells is the subendothelial layer, which is rich in collagen.

  • Smooth Muscle Cells:
      - They contain specific types of receptors critical for contraction.

  • Key Cells Involved:
      - Orange cells represent pain receptors (nociceptors).

Chemical Secretions Preventing Coagulation

  • Nitric Oxide (NO):
      - Secreted by endothelial cells.
      - Purpose: Inhibits platelet aggregation.

  • Prostacyclin (PGI2):
      - Also secreted by endothelial cells.
      - Purpose: Prevents platelet activation, keeping them in an inactive state.

Additional Mechanisms

  • Heparin Sulfate:
      - A glycosaminoglycan (a type of proteoglycan) that acts as a natural anticoagulant.
      - Binds with Antithrombin III, forming a complex that inactivates clotting factors II, IX, and X

  • Thrombomodulin:
      - Binds thrombin (factor II), modifying its activity.
      - When activated, it converts protein C into its active form (activated protein C), which inhibits factors V and VIII.

Summary of Natural Blood Thinness Mechanisms

  • Three primary mechanisms:
      1. Secretion of nitric oxide and prostacyclin to prevent platelet activation and binding to endothelium.
      2. Presence of heparin sulfate, activating antithrombin III to degrade clotting factors.
      3. Action of thrombomodulin, leading to the activation of protein C that further inhibits coagulation factors.

Five Steps of Hemostasis

  1. Vascular Spasm

  2. Platelet Plug Formation

  3. Coagulation

  4. Clot Retraction and Repair

  5. Fibrinolysis

Step 1: Vascular Spasm

  • Definition: A contraction of the smooth muscles lining the blood vessels, triggered by tissue damage.

  • Mechanisms causing vascular spasm:
      1. Endothelial Injury: Damaged endothelial cells release Endothelin, causing vasoconstriction via a receptor-mediated intracellular mechanism (PIP2/Ca2+ pathway).
      2. Myogenic Mechanism: Direct injury to smooth muscle causes it to contract protectively.
      3. Activation of Nociceptors: Neurons stimulated by inflammatory mediators (e.g., histamines, prostaglandins) trigger pain but also reflex vascular spasm.

Step 2: Platelet Plug Formation

  • Von Willebrand Factor (vWF):
      - Secreted by damaged endothelial cells, facilitating platelet binding to exposed collagen.

  • Glycoprotein Receptors:
      - Glycoprotein 1B binds vWF, while Glycoprotein 2B/3A links platelets via fibrinogen in platelet aggregation.

  • Chemicals Released by Activated Platelets:
      - ADP: Enhances platelet aggregation.
      - Thromboxane A2: Causes vasoconstriction and attracts more platelets.
      - Serotonin: Similar effect as thromboxane A2, enhancing vascular spasm.

  • Platelet Aggregation Process:
      - Platelets aggregate at the injury site forming a plug, supported by fibrinogen bridges.

Step 3: Coagulation Cascade

  • Intrinsic Pathway:
      1. Factor XII (Hageman factor) activates Factor XI.
      2. Factor XI activates Factor IX.
      3. Factor IX and Factor VIII together activate Factor X (common pathway initiation).

  • Extrinsic Pathway:
      - Occurs in response to tissue injury leading to the production of tissue factor (TF, Factor III) that activates Factor VII, which can activate Factor IX directly or converge into the common pathway (Factor X activation).

  • Common Pathway:
      - Activation leads to the conversion of prothrombin (Factor II) to thrombin by prothrombin activator. Thrombin converts fibrinogen into fibrin, stabilizing the clot.

Step 4: Clot Retraction and Repair

  • Mechanism: Platelet contraction pulls edges of the injured blood vessel together, reducing the size of the vessel defect.

  • Release of Platelet-Derived Growth Factor (PDGF) stimulates mitosis in smooth muscle and fibers to repair the vessel.

  • Vascular Endothelial Growth Factor (VEGF) stimulates the repair of the endothelial lining.

Step 5: Fibrinolysis

  • Goal: Break down the clot when no longer needed.

  • Tissue Plasminogen Activator (tPA) activates plasminogen, converting it to plasmin, which digests fibrin mesh, facilitating clot removal.

  • d-Dimer Testing: Elevated d-Dimer levels indicate recent clot formation and breakdown; Diagnostic tool for conditions like thrombosis.

Clinical Implications and Drug Treatments

  • Aspirin: Inhibits thromboxane A2 production, reducing platelet aggregation.

  • Clopidogrel (Plavix): ADP receptor inhibitor, reduces platelet activation and aggregation.

  • Glycoprotein IIb/IIIa Inhibitors (e.g., abciximab): Block receptor, preventing fibrinogen linking.

  • Warfarin: Vitamin K antagonist, inhibits synthesis of clotting factors (II, VII, IX, X) that require vitamin K.

  • Direct Thrombin Inhibitors and Factor Xa Inhibitors: Newer anticoagulants that target specific steps in the coagulation cascade directly.